A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment na√Øve Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)